Inveltys 10 mg/mL
Loteprednol Etabonate · SUSPENSION · Alcon Laboratories, Inc.
Inveltys is a suspension containing loteprednol etabonate at 10 mg/mL, taken ophthalmic. Manufactured by Alcon Laboratories, Inc..
Key Facts
- Brand Name
- Inveltys
- Generic Name
- Loteprednol Etabonate
- NDC Code (Product)
0065-9307- Manufacturer
- Alcon Laboratories, Inc.
- Strength
- 10 mg/mL
- Dosage Form
- SUSPENSION
- Route
- OPHTHALMIC
- Marketing Status
- Application #
- NDA210565
- Marketing Start
- 04/16/2026
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
1 INDICATIONS AND USAGE INVELTYS is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery. INVELTYS is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery. ( 1 )
Dosage & Administration
2 DOSAGE AND ADMINISTRATION Shake for one to two seconds before using. ( 2 ) Instill one to two drops of INVELTYS into the affected eye twice daily beginning the day after surgery and continuing throughout the first 2 weeks of the post-operative period. ( 2 ) 2.1 Dosage Information Instill one to two drops of INVELTYS into the affected eye twice daily beginning the day after surgery and continuing throughout the first 2 weeks of the post-operative period. 2.2 Administration Instructions Instruct patient to wash hands well before each use. Shake for one to two seconds before using. If the patient is using other eye drops in addition to INVELTYS , advise the patient to wait at least 5 minutes between instillation of INVELTYS and other eye drops.
Contraindications
4 CONTRAINDICATIONS INVELTYS is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. INVELTYS is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. ( 4 )
Adverse Reactions
6 ADVERSE REACTIONS Adverse reactions associated with ophthalmic steroids include elevated intraocular pressure, which may be associated with infrequent optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, delayed wound healing and secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera. The most common adverse drug reactions were eye pain (1%) and posterior capsular opacification (1%). These reactions may have been the consequence of the surgical procedure. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Alcon Laboratories, Inc. at 1-800-757-9195 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The most common adverse drug reactions in the clinical trials with INVELTYS were eye pain and posterior capsular opacification, both reported in 1% of patients. The…
Frequently Asked Questions
What is Inveltys used for?
Inveltys contains Loteprednol Etabonate. It is a suspension taken ophthalmic. Consult your doctor for specific uses.
Is Inveltys a controlled substance?
Inveltys is not classified as a controlled substance by the DEA.
What is the generic name for Inveltys?
The generic name for Inveltys is Loteprednol Etabonate. There are 11 other brand versions of Loteprednol Etabonate.
What is the NDC code for Inveltys 10 mg/mL?
The NDC (National Drug Code) for Inveltys 10 mg/mL is 0065-9307, listed by Alcon Laboratories, Inc..
Other Loteprednol Brands
See all →- LOTEMAX5 mg/mL24208-299
- LOTEMAX5 mg/g24208-503
- Loteprednol etabonate and Tobramycin5 mg/mL62332-801
- loteprednol etabonate5 mg/mL70748-300
- Loteprednol Etabonate5 mg/g70244-036
- Loteprednol Etabonate5 mg/mL82260-299
- LOTEPREDNOL ETABONATE2 mg/mL0574-4080
- Lotemax SM3.8 mg/g24208-507
- LOTEPREDNOL ETABONATE5 mg/mL60219-1362
- loteprednol etabonate2 mg/mL60219-1366
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)